Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
TNF Inhibitors: Potential for Use in Dermatology Practice
Psoriasis is a chronic inflammatory disease characterized by well-demarcated red, raised, scaly lesions on any part of the body. The disease often severely impacts patients' mental and physical functioning and quality of life. Signs and symptoms may vary from mild to generalized cutaneous involvement, with or without associated joint disease.
Related Videos
Related Content
